Yüklüyor......
Oral 5‐aminosalicylic acid for induction of remission in ulcerative colitis
BACKGROUND: Oral 5‐aminosalicylic acid (5‐ASA) preparations were intended to avoid the adverse effects of sulfasalazine (SASP) while maintaining its therapeutic benefits. It was previously found that 5‐ASA drugs in doses of at least 2 g/day were more effective than placebo but no more effective than...
Kaydedildi:
| Yayımlandı: | Cochrane Database Syst Rev |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Ltd
2020
|
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8189994/ https://ncbi.nlm.nih.gov/pubmed/32786164 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000543.pub5 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|